EUVIMEDEUVIMED entdecken
Crossref

New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol

Fan-Hua Meng, Shuai Liu, Jian Xiao, Yu-Xia Zhou, Le-Wei Dong, Yun-Feng Li, Yan-Qing Zhang, Wei-Hui Li, Ju-Qiong Wang, Yan Wang, Bao-Liang Song, Yi-Tong Ma und 2 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2023

DOI: 10.1161/atvbaha.122.318839 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023. Verfasst von Fan-Hua Meng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center (F.-H.M., S.L., Y.-T.M., Z.-Y.F.), First Affiliated Hospital of Xinjiang Medical University, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Hypercholesterolemia, Atherosclerosis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lower plasma levels of LDL (low-density lipoprotein) cholesterol (LDL-C) can reduce the risk of atherosclerotic cardiovascular disease. The loss-of-function mutations in PCSK9 (proprotein convertase subtilisin/kexin type 9) have been known to associate with low LDL-C in many human populations. PCSK9 genetic variants in Chinese Uyghurs who are at high risk of atherosclerotic cardiovascular disease due to their dietary habits have not been reported.

Methods

The study involved the whole-exome and target sequencing of college students from Uyghur and other ethnic groups in Xinjiang, China, for the association of PCSK9 loss-of-function mutations with low plasma levels of LDL-C. The mechanisms by which the identified mutations affect the function of PCSK9 were investigated in cultured cells using biochemical and cell assays. The causal effects of the identified PCSK9 mutations on LDL-C levels were verified in mice injected with adeno-associated virus expressing different forms of PCSK9 and fed a high-cholesterol diet.

Results

We identified 2 PCSK9 mutations—E144K and C378W—in Chinese Uyghurs with low plasma levels of LDL-C. The E144K and C378W mutations impaired the maturation and secretion of the PCSK9 protein, respectively. Adeno-associated virus–mediated expression of E144K and C378W mutants in Pcsk9 KO (knockout) mice fed a high-cholesterol diet also hampered PCSK9 secretion into the serum, resulting in elevated levels of LDL receptor in the liver and reduced levels of LDL-C in the serum.

Conclusions

Our study shows that E144K and C378W are PCSK9 loss-of-function mutations causing low LDL-C levels in mice and probably in humans as well.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesHypercholesterolemiaAtherosclerosisHumansMiceAnimalsProprotein Convertase 9Cholesterol, LDLSerine EndopeptidasesProprotein ConvertasesReceptors, LDLMice, KnockoutMutation

Stichwörter der Autor:innen

cholesterolexome sequencinglipoproteins LDLloss of function mutationproprotein convertase 9receptors LDL

Substanzen

PCSK9 protein, humanProprotein Convertase 9Cholesterol, LDLSerine EndopeptidasesProprotein ConvertasesReceptors, LDL

Autor:innen und Institutionen

  • Heart Center (F.-H.M., S.L., Y.-T.M., Z.-Y.F.), First Affiliated Hospital of Xinjiang Medical University, China.
  • State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Heart Center (F.-H.M., S.L., Y.-T.M., Z.-Y.F.), First Affiliated Hospital of Xinjiang Medical University, China.
  • College of Life Sciences, Taikang Center for Life and Medical Sciences, Hubei Key Laboratory of Cell Homeostasis, Wuhan University, China (F.-H.M., S.L., J.X., Y.-X.Z., L.-W.D., Y.-F.L., Y.-Q.Z., W.-H.L., J.-Q.W., Y.W.,…
  • Affiliated Hospital of Jining Medical College, Shandong, China (F.-H.M.).

Zitieren

APA

Meng, F. H., Liu, S., Xiao, J., Zhou, Y. X., Dong, L. W., Li, Y. F., Zhang, Y. Q., Li, W. H., Wang, J. Q., Wang, Y., Song, B. L., Ma, Y. T., Fu, Z. Y., & Luo, J. (2023). New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.122.318839

Vancouver

Meng FH, Liu S, Xiao J, Zhou YX, Dong LW, Li YF, et al. New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023. doi:10.1161/atvbaha.122.318839

BibTeX
@article{Meng2023,
  author = {Meng, Fan-Hua and Liu, Shuai and Xiao, Jian and Zhou, Yu-Xia and Dong, Le-Wei and Li, Yun-Feng and Zhang, Yan-Qing and Li, Wei-Hui and Wang, Ju-Qiong and Wang, Yan and Song, Bao-Liang and Ma, Yi-Tong and Fu, Zhen-Yan and Luo, Jie},
  title = {New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2023},
  doi = {10.1161/atvbaha.122.318839}
}
Kostenlos starten →